These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25223697)

  • 1. Interleukin-1 receptor antagonist originating from bone marrowderived cells and non-bone marrow-derived cells helps to suppress arterial inflammation and reduce neointimal formation after injury.
    Isoda K; Akita K; Isobe S; Niida T; Adachi T; Iwakura Y; Daida H
    J Atheroscler Thromb; 2014; 21(11):1208-18. PubMed ID: 25223697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of interleukin-1 receptor antagonist promotes neointimal formation after injury.
    Isoda K; Shiigai M; Ishigami N; Matsuki T; Horai R; Nishikawa K; Kusuhara M; Nishida Y; Iwakura Y; Ohsuzu F
    Circulation; 2003 Aug; 108(5):516-8. PubMed ID: 12874179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory response to acute myocardial infarction augments neointimal hyperplasia after vascular injury in a remote artery.
    Takaoka M; Uemura S; Kawata H; Imagawa K; Takeda Y; Nakatani K; Naya N; Horii M; Yamano S; Miyamoto Y; Yoshimasa Y; Saito Y
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2083-9. PubMed ID: 16778119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central role of endogenous Toll-like receptor-2 activation in regulating inflammation, reactive oxygen species production, and subsequent neointimal formation after vascular injury.
    Shishido T; Nozaki N; Takahashi H; Arimoto T; Niizeki T; Koyama Y; Abe J; Takeishi Y; Kubota I
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1446-53. PubMed ID: 16730663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syndecan-4 deficiency limits neointimal formation after vascular injury by regulating vascular smooth muscle cell proliferation and vascular progenitor cell mobilization.
    Ikesue M; Matsui Y; Ohta D; Danzaki K; Ito K; Kanayama M; Kurotaki D; Morimoto J; Kojima T; Tsutsui H; Uede T
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1066-74. PubMed ID: 21330609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 mobilizes bone marrow-derived cells to the vascular wall, resulting in neointima formation via inflammatory effects.
    Shoji M; Furuyama F; Yokota Y; Omori Y; Sato T; Tsunoda F; Iso Y; Koba S; Geshi E; Katagiri T; Suzuki H; Kobayashi Y
    J Atheroscler Thromb; 2014; 21(4):304-12. PubMed ID: 24366256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 2-deficiency on bone marrow-derived cells augments vascular healing of murine arterial lesions.
    Liu W; Eczko JC; Otto M; Bajorat R; Vollmar B; Roesner JP; Wagner NM
    Life Sci; 2020 Feb; 242():117189. PubMed ID: 31891724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of bone marrow apoptosis-associated speck-like protein, an inflammasome adaptor molecule, in neointimal formation after vascular injury in mice.
    Yajima N; Takahashi M; Morimoto H; Shiba Y; Takahashi Y; Masumoto J; Ise H; Sagara J; Nakayama J; Taniguchi S; Ikeda U
    Circulation; 2008 Jun; 117(24):3079-87. PubMed ID: 18541743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1 from bone marrow-derived cells suppresses neointimal formation after vascular injury in mice.
    Schäfer K; Schroeter MR; Dellas C; Puls M; Nitsche M; Weiss E; Hasenfuss G; Konstantinides SV
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1254-9. PubMed ID: 16514083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of tumour necrosis factor-alpha and interferon-gamma in bone marrow cells synergistically inhibits neointimal formation following vascular injury.
    Murayama H; Takahashi M; Takamoto M; Shiba Y; Ise H; Koyama J; Tagawa Y; Iwakura Y; Ikeda U
    Cardiovasc Res; 2008 Nov; 80(2):175-80. PubMed ID: 18791204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl-peptidase-4 inhibitor, alogliptin, attenuates arterial inflammation and neointimal formation after injury in low-density lipoprotein (LDL) receptor-deficient mice.
    Akita K; Isoda K; Shimada K; Daida H
    J Am Heart Assoc; 2015 Mar; 4(3):e001469. PubMed ID: 25770025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice.
    Bamba S; Lee CY; Brittan M; Preston SL; Direkze NC; Poulsom R; Alison MR; Wright NA; Otto WR
    J Pathol; 2006 Jun; 209(2):265-73. PubMed ID: 16550633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of interleukin-1 receptor antagonist on arteries and cholesterol metabolism.
    Isoda K; Ohsuzu F
    J Atheroscler Thromb; 2006 Feb; 13(1):21-30. PubMed ID: 16505588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation.
    Sahara M; Sata M; Morita T; Nakamura K; Hirata Y; Nagai R
    Circulation; 2007 Jan; 115(4):509-17. PubMed ID: 17242277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of interleukin-1 receptor antagonist promotes spontaneous femoral artery aneurysm formation in mice.
    Isoda K; Kitagaki M; Niida T; Kondo H; Matsubara O; Kikuchi M; Ohsuzu F; Adachi T
    Am J Pathol; 2012 Mar; 180(3):1254-1263. PubMed ID: 22245214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist.
    Lu P; Li L; Liu G; Zhang X; Mukaida N
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4761-8. PubMed ID: 19458323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide of Aggregatibacter actinomycetemcomitans up-regulates inflammatory cytokines, prostaglandin E2 synthesis and osteoclast formation in interleukin-1 receptor antagonist-deficient mice.
    Mizutani H; Ishihara Y; Izawa A; Fujihara Y; Kobayashi S; Gotou H; Okabe E; Takeda H; Ozawa Y; Kamiya Y; Kamei H; Kikuchi T; Yamamoto G; Mitani A; Nishihara T; Noguchi T
    J Periodontal Res; 2013 Dec; 48(6):748-56. PubMed ID: 23586622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The origin of post-injury neointimal cells in the rat balloon injury model.
    Rodriguez-Menocal L; St-Pierre M; Wei Y; Khan S; Mateu D; Calfa M; Rahnemai-Azar AA; Striker G; Pham SM; Vazquez-Padron RI
    Cardiovasc Res; 2009 Jan; 81(1):46-53. PubMed ID: 18818213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel TNF-α receptor 1 antagonist treatment attenuates arterial inflammation and intimal hyperplasia in mice.
    Kitagaki M; Isoda K; Kamada H; Kobayashi T; Tsunoda S; Tsutsumi Y; Niida T; Kujiraoka T; Ishigami N; Ishihara M; Matsubara O; Ohsuzu F; Kikuchi M
    J Atheroscler Thromb; 2012; 19(1):36-46. PubMed ID: 22146239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted disruption of the prostaglandin E2 E-prostanoid 2 receptor exacerbates vascular neointimal formation in mice.
    Zhu S; Xue R; Zhao P; Fan FL; Kong X; Zheng S; Han Q; Zhu Y; Wang N; Yang J; Guan Y
    Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1739-47. PubMed ID: 21636806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.